期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

癫痫儿童学习障碍的研究进展

下载PDF
导出
摘要 学习障碍(LD)是一组异质性综合征,指智力正常儿童在阅读、书写、拼字、表达、计算等方面的基本心理过程存在的一种或一种以上的特殊性障碍。癫痫儿童的LD分为永久性和症状依赖性两种。症状依赖性LD未经治疗可发展为永久性LD,可显著影响患儿生活质量。本文就癫痫儿童合并LD的定义和分类、流行病学情况、发病影响因素、防治现状等进行综述。
作者 童玉翠 周农
机构地区 安徽医科大学第一附属医院神经内科
出处 《国际神经病学神经外科学杂志》 2010年第1期62-65,共4页 Journal of International Neurology and Neurosurgery
关键词 学习障碍 癫痫儿童 流行病学 临床治疗
分类号 R742.1 [医药卫生—神经病学与精神病学]
  • 相关文献

参考文献30

  • 1American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association, 2000.
  • 2Sillanpaa M. Epilepsy in children : prevalence, disability, and handicap. Epilepsia, 1992, 33 (3) : 444-449.
  • 3Beghi M, Cornaggia CM, Frigeni B, et al. Learning Disorders in Epilepsy. Epilepsia, 2006, 47 (Suppl. 2) : 14- 18.
  • 4Cornaggia CM, Gobbi G. Learning disability in epilepsy : definition and classification. Epilepsia, 2001 , 42 (suppl 1 ) : 2-5.
  • 5Besag FM. Treatment of state-dependent learning disbility. Epilepsia, 2001, 42( suppl 1 ) : 52-54.
  • 6Rutter M, Caspi A, Fergusson D, et al. Sex differences in developmental reading disability : new findings from 4 epidemiological studies. JAMA, 2004, 291: 2007-2012.
  • 7Lyon GR. Learning disabilities. Future Child, 1996, 6 (1) : 54-76.
  • 8Roongpraiwan R, Ruangdaraganon N, Visudhiphan P, et al. Prevalence and clinical characteristics of dyslexia in primary school. J Med Assoc Thai, 2002, 85 (suppl 4) : 1097- 1103.
  • 9Shalev RS, Auerbach J, Manor O, et al. Developmental dyscalculia: prevalence and prognosis. Eur Child Adolesc Psychiatry, 2000 ; 9 ( suppl 2 ) : II58-64.
  • 10Cowan LD. The epidemiology of the epilepsies in children. Ment Retard Dev Disabil Res Rev, 2002, 8 (3): 171- 181.

二级参考文献24

  • 1Krauss GL, Betts T, Abou-Khalil B, et al. Levetiracetam treatment of idiopathic generalised epilepsy. Seizure, 2003, 12(8) : 617-620.
  • 2Specchio LM, Gambardella A, Giallonardo AT, et al. Open label, long-term, pragmatic study on levetiracetam in the treatment of juvenile myoclonic epilepsy. Epilepsy Res, 2006, 71(1) : 32-39.
  • 3Berkovic SF, Knowlton RC, Leroy RF, et al. Levetiracetam NO 1057 Study Group. Placebo-controlled study of levetirace- tam in idiopathic generalized epilepsy. Neurology, 2007, 69 (18): 1734-1736.
  • 4Specchio N, Boero G, Michelucci R, et al. Effects of levetiracetam on EEG abnormalities in juvenile myoclonic epilepsy. Epilepsia, 2008, 49(4) : 663-669.
  • 5Verrotti A, Cerminara C, Coppola G, et al. Levetiracetam in juvenile myoclonic epilepsy: long-term efficacy in newly diagnosed adolescents. Dev Med Child Neurol, 2008, 50( 1 ): 29-32.
  • 6Arroyo S, Crawford P. Safety profile of levetiracetam. Epileptic Dis, 2003, 5(1): 57-63.
  • 7Gomer B, Wagner K, Frings L, et al. The influence of antiepileptic drugs on cognition: a comparison of levetiracetam with topiramate. Epilepsy Behav, 2007, 10 ( 3 ) : 486-494.
  • 8Cramer JA, Van Hammre G; N132 Study Group, Maintenance of improvement in health-related quality of life during long-term treatment with levetiraeetam. Epilepsy Behav, 2003, 4(2) : 118-123.
  • 9Von Rosenstiel P. Brivaracetam (UCB 34714). Neurotherapeutics, 2007 Jan ; 4 ( 1 ) :84-87.
  • 10Matagne A, Margineanu DG, Kenda B, et al. Anti-convulsive and anti-epileptic properties of brivaracetam (ucb 34714 ) , a high-affinity ligand for the synaptic vesicle protein, SV2 A. Br J Pharmacol, 2008, 154(8) : 1662-1671.

共引文献8

国际神经病学神经外科学杂志
2010年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部